# Phase 3 sepsis trials recruiting: 20 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 20 trials in phase 3 for sepsis that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 3 sepsis trials: 20 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 1 row a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-3/sepsis

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 20
- Recruiting or not yet: 20
- Read on: November 19, 2026

## Trials

The 20 newest of 20, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| October 27, 2026 | NCT07898462 | A Trial of Adjunctive Fludrocortisone (50mcg, 100mcg or Placebo) in Critically Ill Patients With Septic Shock Receiving Hydrocortisone... | The George Institute | Phase 3 | Recruiting | Septic Shock | 2,200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07898462) |
| September 22, 2026 | NCT07834346 | CLARITHROMYCIN TO PREVENT SECONDARY INFECTIONS IN PATIENTS WITH SEPSIS FOLLOWING LOWER RESPIRATORY TRACT INFECTIONS: THE CLASSIFY TRIAL | Hellenic Institute for the Study of Sepsis | Phase 3 | Recruiting | Sepsis | 252 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07834346) |
| September 10, 2026 | NCT07813767 | THE ROLE OF PANCREATIC STONE PROTEIN (PSP) AND PSP-GUIDED EARLY MEROPENEM TREATMENT TO MITIGATE SEPSIS RISK AT THE EMERGENCY DEPARTMENT... | Hellenic Institute for the Study of Sepsis | Phase 3 | Recruiting | Sepsis | 398 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07813767) |
| May 8, 2026 | NCT07576660 | Dexamethasone Treatment for Sepsis-associated Acute Respiratory Distress Syndrome: a Multicenter, Randomised, Double-blinded, Controlled... | Southeast University, China | Phase 3 | Recruiting | Acute Respiratory Distress Syndrome (ARDS) | 1,704 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07576660) |
| May 8, 2026 | NCT07575009 | Continuous Antibiotic Infusion In Children | Tampere University Hospital | Phase 3 | Recruiting | Infection | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07575009) |
| May 6, 2026 | NCT07569536 | Efficacy of the Alpha 2 Agonist Dexmedetomidine for Sympathetic Deactivation in REfractory Septic Shock | Hospices Civils de Lyon | Phase 3 | Not yet recruiting | Septic Shock, Vasopressor Resistance | 360 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07569536) |
| April 24, 2026 | NCT07550894 | Phosphate-Containing Replacement Fluid for Patients Undergoing CRRT | Sun Yat-sen University | Phase 3 | Not yet recruiting | Acute Kidney Injury, Sepsis, Critically Ill Patients Requiring Continuous Renal Replacement Therapy | 220 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07550894) |
| February 12, 2026 | NCT07407673 | Prediction and Prevention of Bloodstream Infections After Kidney Transplantation | Sponsor not shown (see the record) | Phase 3 | Not yet recruiting | Kidney Transplant Infection, Bloodstream Infection, Kidney Transplant, Kidney Transplant Recipients, Infection, Urinary... | 180 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07407673) |
| February 2, 2026 | NCT07380347 | Effect of N-acetylcysteine as Adjunct Therapy on the Clinical Outcome of Neonatal Sepsis | Ain Shams University | Phase 3 | Not yet recruiting | Neonatal Sepsis | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07380347) |
| January 12, 2026 | NCT07332325 | STeroids and Enhanced Spectrum Antibiotics for the Treatment of Patients in Africa With Refractory Sepsis | University of Virginia | Phase 3 | Not yet recruiting | Sepsis, Tuberculosis | 344 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07332325) |
| July 28, 2025 | NCT07089186 | Study to Assess the Efficacy and Safety of Meropenem and Pralurbactam in Carbapenem-Resistant Enterobacteriaceae Infections | Qilu Pharmaceutical Co., Ltd. | Phase 3 | Recruiting | Hospital-acquired Bacterial Pneumonia (HABP), Ventilator-associated Bacterial Pneumonia (VABP), Complicated... | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07089186) |
| July 14, 2025 | NCT07063095 | A Combination Therapy With Ceftazidime and Fosfomycin Will be Compared to Ceftazidime Alone in Hospitalized Adult Patients With Suspected... | Sponsor not shown (see the record) | Phase 3 | Recruiting | Gram Negative Infections, Sepsis and Septic Shock | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07063095) |
| November 20, 2024 | NCT06696391 | Venous Excess Ultrasound for Personalized Resuscitation in Septic Shock | Western University, Canada | Phase 3 | Not yet recruiting | Septic Shock, Sepsis, Shock, Critical Care, Intensive Care, Resuscitation | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06696391) |
| June 25, 2024 | NCT06472219 | PREDICATE Trial For Respiratory Tract Infections | The University of Hong Kong | Phase 3 | Recruiting | Respiratory Tract Infections | 1,300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06472219) |
| April 22, 2024 | NCT06377397 | Selective Antibiotics When Symptoms Develop Versus Universal Antibiotics for Preterm Neonates | Indian Council of Medical Research | Phase 3 | Recruiting | Sepsis, PROM, Preterm (Pregnancy), Early-Onset Neonatal Sepsis, Preterm Premature Rupture of Membrane, Preterm Birth | 1,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06377397) |
| May 6, 2023 | NCT05843786 | Human Recombinant Interferon Gamma in the Treatment of Ventilator-acquired Pneumonia in ICU Patients | Hospices Civils de Lyon | Phase 3 | Recruiting | Pneumonia, Ventilator-Associated | 132 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05843786) |
| January 5, 2022 | NCT05179499 | Early Vasopressors in Sepsis | NHS Greater Glasgow and Clyde | Phase 3 | Recruiting | Sepsis | 1,006 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05179499) |
| June 2, 2021 | NCT04910464 | Early Tranexamic Acid and Modulating the Inflammatory Response in Sepsis | Assiut University | Phase 3 | Recruiting | Sepsis | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04910464) |
| March 2, 2020 | NCT04292054 | Antibioprophylaxis for Excision-graft Surgery in Burn Patient (A2B-TRIAL) | Assistance Publique - Hôpitaux de Paris | Phase 3 | Recruiting | Burns Surgery | 506 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04292054) |
| January 17, 2018 | NCT03401398 | Stress Hydrocortisone In Pediatric Septic Shock | Sponsor not shown (see the record) | Phase 3 | Recruiting | Septic Shock | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03401398) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Hellenic Institute for the Study of Sepsis | 2 |
| Hospices Civils de Lyon | 2 |
| Assiut University | 1 |
| Western University, Canada | 1 |
| Ain Shams University | 1 |
| The University of Hong Kong | 1 |
| [Qilu Pharmaceutical Co., Ltd.](https://specstream.ai/data/clinical-trials/company/qilu-pharmaceutical-co-ltd) | 1 |
| Sun Yat-sen University | 1 |
| The George Institute | 1 |
| Tampere University Hospital | 1 |
| University of Virginia | 1 |
| Southeast University, China | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| NHS Greater Glasgow and Clyde | 1 |
| Indian Council of Medical Research | 1 |

## By country

| Country | Trials |
| --- | --- |
| China | 3 |
| France | 3 |
| Canada | 2 |
| Greece | 2 |
| Egypt | 1 |
| Brazil | 1 |
| Israel | 1 |
| Japan | 1 |
| Malaysia | 1 |
| Pakistan | 1 |
| Saudi Arabia | 1 |
| Singapore | 1 |
| United States | 1 |
| Vietnam | 1 |
| Denmark | 1 |
| Hong Kong | 1 |
| Australia | 1 |
| Finland | 1 |
| Tanzania | 1 |
| Uganda | 1 |
| United Kingdom | 1 |
| India | 1 |
| Switzerland | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Dermatology practices in the United States](https://specstream.ai/data/businesses/dermatology-practices/united-states)
- [Private equity firms in the United States](https://specstream.ai/data/businesses/private-equity-firms/united-states)
- [Chinese restaurants in the United States](https://specstream.ai/data/businesses/chinese-restaurants/united-states)
- [Packing services in the United States](https://specstream.ai/data/businesses/packing-services/united-states)
- [Biotechnology companies in the United States](https://specstream.ai/data/businesses/biotechnology-companies/united-states)
- [Medical sciences schools in the United States](https://specstream.ai/data/businesses/medical-sciences-schools/united-states)
